We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Updates Policies on Expedited Review of Prior Approval Supplements
CDER Updates Policies on Expedited Review of Prior Approval Supplements
CDER released a revised Manual of Policies and Procedures on expedited reviews of prior approval supplements for new drug and biologics license applications that involve chemistry, manufacturing and controls changes.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor